Trial
NCT00492947
Dendritic Cell Vaccine for Head and Neck Cancer
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Maryland, Baltimore
Collaborators
—
Condition
Squamous Cell Carcinoma of Head and Neck
Intervention
dendritic cell vaccine
Why stopped
major amendments in progress
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-30